News
Thermo Fisher Scientific Inc. just made headlines with its hefty $17.6 billion acquisition of PPD, Inc., aiming to bolster ...
Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.
Casper claimed that during the quarter, Thermo Fisher advanced its growth strategy, launching a range of high-impact ...
Q2 2025 Earnings Call Transcript July 23, 2025 Thermo Fisher Scientific Inc. beats earnings expectations. Reported EPS is ...
In the bustling realm of life sciences, Thermo Fisher Scientific shows formidable resilience and innovation. The company's Q2 2025 earnings reveal a revenue of $10.85 billion, marking a 3% ...
Key Points - Revenue rose 3.0 % year over year to $10.85 billion, surpassing analyst expectations.- Non-GAAP earnings per ...
Thermo Fisher Scientific (NYSE:TMO) stock gains as company beats Q2 2025 forecasts with $10.9B revenue, driven by Life ...
Thermo Fisher Scientific's second quarter of 2025 demonstrated a 3% revenue increase to $10.85 billion, slightly surpassing ...
The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV ...
Sanofi has completed its acquisition of Blueprint Medicines, enhancing its portfolio with a commercialised therapy and the ...
Thermo Fisher is acquiring Sanofi’s Ridgefield, NJ sterile drug plant, transferring 200 employees to bolster U.S. fill‑finish ...
The transaction between Thermo Fisher and Sanofi is scheduled for completion in Q2 2025, subject to standard closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results